thiazoles has been researched along with Mast Cell Activation Disease in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akin, C; Bindslev-Jensen, C; Broesby-Olsen, S; Maurer, M; Siebenhaar, F | 1 |
Alfonso, A; Botana, LM; TobĂo, A | 1 |
Bauer, K; Cerny-Reiterer, S; Hadzijusufovic, E; Hoermann, G; Pirker, A; Reifinger, M; Valent, P; Willmann, M | 1 |
Avanzo, JL; Caetano, HV; Dagli, ML; Fukumasu, H; Matera, JM; Matsuzaki, P; Nagamine, M; Pinello, KC; Silva, TC; Torres, LN | 1 |
Barete, S; Damaj, G; Georgin-Lavialle, S; Gineste, P; Hermine, O; Lortholary, O; Montestruc, F; Moura, DS; Moussy, A; Pillet, N; Sultan, S | 1 |
1 review(s) available for thiazoles and Mast Cell Activation Disease
Article | Year |
---|---|
Treatment strategies in mastocytosis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Bone and Bones; Central Nervous System; Dasatinib; Gastrointestinal Tract; Gene Expression; Histamine Antagonists; Humans; Mast Cells; Mastocytosis; Omalizumab; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Skin; Thiazoles | 2014 |
1 trial(s) available for thiazoles and Mast Cell Activation Disease
Article | Year |
---|---|
Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Depression; Female; Humans; Male; Mastocytosis; Middle Aged; Piperidines; Pyridines; Thiazoles; Young Adult | 2011 |
3 other study(ies) available for thiazoles and Mast Cell Activation Disease
Article | Year |
---|---|
PKC potentiates tyrosine kinase inhibitors STI571 and dasatinib cytotoxic effect.
Topics: Apoptosis; Benzamides; Cell Line, Tumor; Dasatinib; Drug Synergism; Enzyme Activation; Flow Cytometry; Humans; Imatinib Mesylate; Mastocytosis; Piperazines; Protein Kinase C; Protein Kinase C-delta; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Thiazoles; Transfection | 2014 |
IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Brentuximab Vedotin; Cell Line, Tumor; Cytokines; Dog Diseases; Dogs; Down-Regulation; Drug Synergism; Female; Immunoconjugates; Interleukin-4; Ki-1 Antigen; Male; Mastocytosis; Piperidines; Pyridines; Staurosporine; Thiazoles | 2017 |
In vitro chemosensitivity of canine mast cell tumors grades II and III to all-trans-retinoic acid (ATRA).
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Male; Mast Cells; Mastocytosis; Tetrazolium Salts; Thiazoles; Tretinoin; Tumor Cells, Cultured | 2009 |